However, this trend did not reach statistical significance at the interim analysis ( p = 0.019).
← all excerpts
Immune Checkpoint Inhibitors and Targeted Therapies in Early-Stage Non-Small-Cell Lung Cancer: State-of-the-Art and Future Perspectives.
1
0.0190
0.0190